SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000950159-12-000430
Filing Date
2012-07-27
Accepted
2012-07-27 11:23:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 QUAKER BIOVENTURES II, L.P. FORM SC 13G sc13g.htm SC 13G 118103
  Complete submission text file 0000950159-12-000430.txt   119662
Mailing Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104
Business Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104 (215) 988-6800
Quaker BioVentures II LP (Filed by) CIK: 0001497725 (see all company filings)

IRS No.: 205328033 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 89 HEADQUARTERS PLAZA NORTH 14TH FLOOR MORRISTOWN NJ 09760
Business Address 89 HEADQUARTERS PLAZA NORTH 14TH FLOOR MORRISTOWN NJ 09760 973-993-4867
Durata Therapeutics, Inc. (Subject) CIK: 0001544116 (see all company filings)

IRS No.: 871247903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86923 | Film No.: 12989403
SIC: 2834 Pharmaceutical Preparations